0000899243-22-007496.txt : 20220223 0000899243-22-007496.hdr.sgml : 20220223 20220223200012 ACCESSION NUMBER: 0000899243-22-007496 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220218 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rivera Victor CENTRAL INDEX KEY: 0001876623 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40869 FILM NUMBER: 22665842 MAIL ADDRESS: STREET 1: 210 BROADWAY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theseus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001745020 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830712806 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (857) 400-9491 MAIL ADDRESS: STREET 1: 245 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-18 0 0001745020 Theseus Pharmaceuticals, Inc. THRX 0001876623 Rivera Victor C/O THESEUS PHARMACEUTICALS, INC. 245 MAIN STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Scientific Officer Stock Option (right to buy) 11.21 2022-02-18 4 A 0 130000 0.00 A 2032-02-17 Common Stock 130000 130000 D The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 25% of the options vesting on February 18, 2023 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer. /s/ Bradford Dahms - Attorney-in-Fact 2022-02-23